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Background: The thalassaemias are the commonest blood disorders worldwide, with South East Asia and
southern China as areas of high prevalence. Accurate diagnosis of these disorders helps in clinical
management with improved outcome.
Methods: The a-globin genotypes of 100 Chinese patients in Hong Kong with haemoglobin H (Hb H) disease
were characterised. Single-tube multiplex gap-PCR was used to detect 22SEA, 2a3.7 and 2a4.2, while
Hb CS, Hb QS and codon 30 (DGAG) were identified by single-tube multiplex amplification refractory
mutation system (ARMS). Automated direct nucleotide sequencing of the amplified a2- and a1-globin genes
was performed to characterise other non-deletional a-thalassaemia determinants.
Results: In the 100 cases studied, 99 cases had 22SEA in combination with deletional a+-thalassaemia or
non-deletional a-globin gene mutation involving the a2-globin gene. In 70 cases of the deletional form, 43
cases showed the genotype of (22SEA/2a3.7) and 27 cases of (22SEA/2a4.2). Three of the 27 cases of
(22SEA/2a4.2) were found to have Hb Q-Thailand linked in-cis with 2a4.2. The remaining 30 cases were of
non-deletional form with the following genotypes: 11 cases of (22SEA/aHbCSa), 9 cases of (22SEA/aHbQSa),
3 cases of (22SEA/acd30 (DGAG)a), 3 cases of (22SEA/acd31a), 2 cases of (22SEA/apoly-Aa), 1 case of
(22SEA/aHbWestmeada) and 1 case of (22non-SEA/aHbQSa).
Conclusions: Based on two rapid diagnostic tests, multiplex gap-PCR and multiplex ARMS, more than 90% of
the cases were genetically characterised. This laboratory strategy should be widely applicable for genetic
diagnosis of a-thalassaemia.
T
he a-thalassaemia syndromes represent a common genetic
disorder due to an absence or diminished synthesis of a
globin chain of the haemoglobin (Hb) molecule. The
human globin gene cluster is located on chromosome
16p13.3-pter. This cluster contains three genes and four
pseudogenes arranged as follows: 59 f2-yf1-ya2-ya1-a2-a1-
h1 39. a-Thalassaemia frequently results from deletions of a-
globin genes. Non-deletional mutations involving single to a
few nucleotides within the structural genes account for a small
proportion of cases.1 2
a-Thalassaemia traits are caused by deletion or non-
deletional mutation of one (2a/aa, aTa/aa or aaT/aa) or two
(22/aa or 2a/2a) a-globin genes. Patients with Hb H disease
show loss or inactivation of three a-globin genes (22/2a or
22/aTa or 22/aaT). They have a moderately severe haemolytic
anaemia with a variable clinical course. In Hb Bart’s hydrops
fetalis (22/22), severe intrauterine anaemia develops that
results in fetal death at or around the time of birth.1 3 4
Population studies have indicated that the types and
frequencies of the different a-thalassaemia defects vary among
different ethnic groups.1 In Hong Kong, the commonest a˚ -
thalassaemia determinant is the South East Asian deletion
(22SEA) which removes nearly 20 kb DNA of the a-globin gene
cluster.5 The common a+-thalassaemia determinants are the
rightward deletion (2a3.7) and leftward deletion (2a4.2).5 6 The
more common non-deletional a2-thalassaemia determinants
include Hb Constant Spring (Hb CS), Hb Quong Sze (Hb QS)
and codon 30 (DGAG).5 6 As Hb H disease follows a variable
clinical course ranging from asymptomatic to multi-organ
morbidity, the latter more associated with non-deletional
forms, there is a rationale for early and accurate diagnosis of
Hb H disease at the genotypic level prior to onset of com-
plications. Improved patient care for patients with high risk
Hb H disease may be achieved with laboratory and clinical
monitoring. In this study, we present a rapid and simple
laboratory approach for molecular diagnosis of Hb H disease.
MATERIALS AND METHODS
Patient samples
Between 1998 and 2003, 100 cases of Hb H disease (97 Chinese,
2 Thais, 1 Filipino) were diagnosed by routine haemoglobin
study. Seven cases were related, coming from three families
with Hb H disease. The age range was 1–84 years, with more
than two-thirds of the patients older than 20 years and one-
third older than 40 years.
DNA analysis
Genomic DNA was extracted from peripheral blood of patients.
Multiplex gap-PCR7 was adopted and modified to detect
22SEA,2a3.7 and2a4.2. Genomic DNA samples were amplified
in a GeneAmp9700 thermocycler using the following cycling
parameters: initial denaturation at 95 C˚ for 15 min, followed by
30 cycles of 98 C˚ denaturing for 45 s, 60 C˚ annealing for 1 min
30 s, and 72 C˚ extension 2 min 15 s. A final 5 min extension
completed the reaction. Each PCR was set up in a total volume
of 50 ml containing: 300–600 ng genomic DNA, 200 mM of each
dNTP, 1.5 mM MgCl2, 16 Q-solution (Qiagen, Hilden,
Germany), 2.5 U HotStarTaq DNA polymerase in supplied
reaction buffer (Qiagen) and 9 different primers at various
concentrations (table 1). A 10 ml aliquot of each amplified
product was analysed by electrophoresis on a 1% agarose gel
after staining with ethidium bromide.
For the detection of the three common non-deletional a2-
thalassaemia determinants, Hb CS, Hb QS and codon 30
(DGAG), the multiplex amplification refractory mutation
Abbreviations: ARMS, amplification refractory mutation system; Hb,
haemoglobin
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system (ARMS)8 approach was modified and used. Genomic
DNA samples were amplified in a GeneAmp9700 thermocycler
using the following cycling parameters: initial denaturation at
94 C˚ for 12 min, followed by 32 cycles of 94 C˚ denaturing for
40 s, 62 C˚ annealing for 20 s, and 72 C˚ extension 3 min. A final
7 minutes extension completed the reaction. Each PCR was set
up in a total volume of 20 ml containing: 200 mM of each dNTP,
2.0 mM MgCl2, 10% dimethysulphoxide, 16.5 mM ammonium
sulphate, 0.01% (w/v) gelatin, 10 mM Tris-HCl, pH 8.3, 50 mM
KCl, 5 U AmpliTaq Gold DNA polymerase and 6 different
primers at various concentrations (table 1). A 10 ml aliquot of
each amplified product was analysed by electrophoresis on a 8%
non-denaturing polyacrylamide gel after staining with ethi-
dium bromide.
Automated direct nucleotide sequencing (ABI 377, Applied
Biosystems, Foster City, California, USA) of the amplified a2-
and a1-globin genes was performed to characterise other non-
deletional a-thalassaemia determinants.9
RESULTS
Table 2 presents results of a genotyping for all cases. All except
one were caused by co-inheritance of 22SEA with either
deletional or non-deletional a+-thalassaemia determinants.
Deletional Hb H disease, that is 22SEA in association with
a+-deletion (2a3.7 and 2a4.2), accounted for 70% of the cases.
Figure 2 shows the electrophoretic results of multiplex gap-PCR
product in deletional Hb H disease on 1% agarose gel. Three
cases of (22SEA/2a4.2) were also found to have Hb Q-
Thailand10 11 linked in-cis with 2a4.2 by direct nucleotide
sequencing of the amplified a1-globin gene.
Among the remaining 30% of cases with Hb H disease, six
different types of non-deletional determinants were found, all
in the a2-globin gene. They were Hb CS, Hb QS, codon 30
(DGAG),12 codon 31 (AGGRAAG),13 poly-A signal
(AATAAARAATGAA)14 and Hb Westmead (codon 122
CACRCAG).14 15 Our multiplex ARMS detected Hb CS, Hb QS
and codon 30 (DGAG) and resolved 80% (ie 24/30) of the non-
deletional cases. Figure 3 shows the electrophoretic results of
three common non-deletional Hb H disease as detected by our
multiplex ARMS in an aqueous 8% polyacrylamide gel.
The remaining three non-deletional determinants were
characterised by direct nucleotide sequencing of the amplified
a2-globin gene. They were codon 31 (AGGRAAG),13 poly-A
signal AATAAARAATGAA14 and Hb Westmead (codon 122
CACRCAG).14 15 Figure 4 illustrates the automated sequencing
result of codon 31 (AGGRAAG).
DISCUSSION
The clinical severity of Hb H disease is known to be variable. There
is evidence to show a more severe phenotype with non-deletional
forms (22/aTa) compared with deletional forms (22/2a),3 4 16–18
which leads to the view that Hb H disease is not as benign a
disorder as previously thought.18 Patients with non-deletional
forms of Hb H may have significant anaemia, iron overload and
multi-organ morbidity. An early and accurate diagnosis of Hb H
disease is therefore warranted. Many methods for genetic
diagnosis of a-thalassaemia are currently in use, including
Southern blot analysis, direct nucleotide sequencing and reverse
dot-blotting.19 However, these approaches are labour-intensive
and time-consuming. With our diagnostic strategy (fig 1), more
than 90% of Hb H disease in our population can be characterised
Table 1 Primer sequences for a-thalassaemia multiplex gap-PCR and multiplex amplification refractory mutation system (ARMS)
assay
Allele detected Name Primer sequences (59 R 39) Conc (mM) Fragment (bp)
a-thalassaemia multiplex gap-PCR
LIS 39UTR fragment LIS1 (forward) ATACCATGGTTACCCCATTGAGC 0.5 2350
(internal control) LIS1 (reverse) AGGGCTCATTACATGTGGACCC 0.5
2a3.7 a2/3.7 (forward) CCCCTCGCCAAGTCCACCC 0.2 2022/2029
3.7 (reverse) AAAGCACTCTAGGGTCCAGCG 0.2
a2 gene a2/3.7 (forward) as above – 1800
a2 (reverse) AGACCAGGAAGGGCCGGTG 0.2
2a4.2 4.2 (forward) GGTTTACCCATGTGGTGCCTC 0.5 1628
4.2 (reverse) CCCGTTGGATCTTCTCATTTCCC 0.5
22SEA SEA (forward) CGATCTGGGCTCTGTGTTCTC 0.2 1349
SEA (reverse) AGCCCACGTTGTGTTCATGGC 0.2
a-thalassaemia multiplex ARMS assay
f2-globin gene fragment ENG12 (forward) GGATCCACGCAGTGCTAGAAG 0.294 930*
(internal control) ENG21 (reverse) GTAGAGATGGTGTTTTGCCATGT 0.294
codon 30 (DGAG) ARMSC30 (forward) GTATGGTGCGGAGGCCCTGAG 0.074 772
BE17 (reverse) CCATTGTTGGCACATTCCGGGA 0.140
codon 125 (CTGRCCG) ARMSC125 (forward) CACCCCTGCGGTGCACGCCTCACC 0.013 234
Hb Quong Sze BE17 (reverse) as above –
Termination codon (TAARCAA) ARMSC142 (forward) CCGTGCTGACCTCCAAATACGGTC 0.096 184
Hb Constant Spring BE17 (reverse) as above –
*This fragment migrates at ,1200 bp on non-denaturing polyacrylamide gels.
Table 2 a-Globin genotypes of 100 patients with Hb H
disease
No
Deletional
(22SEA/2a3.7) 43
(22SEA/2a4.2) 24
(22SEA/2a4.2 Q-Thailand [Codon 74 GACRCAC or AspRHis]) 3
Subtotal: 70
Non-deletional
(22SEA/aConstant Spring [Codon 142 TAARCAA or TermRGln]a) 11
(22SEA/aQuong Sze [Codon 125 CTGRCCG or LeuRPro]a) 9
(22SEA/aCodon 30 deletion of GAGa) 3
(22SEA/aCodon 31 AGGRAAG or ArgRLysa) 3`
(22SEA/aPoly-A signal AATAAARAATGAAa) 21
(22SEA/aWestmead [Codon 122 CACRCAG or His RGln]a) 1
(22Non-SEA/aQuong Sze [Codon 125 CTGRCCG or LeuRPro]a) 1
Subtotal: 30
Total: 100
*Two individuals had concomitant b-thalassaemia trait (one 22SEA/2a3.7,
one 22SEA/aQuong Szea)
Three are brother and sister.
`Two are brother and sister.
1Two are brother and sister.
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by performing only two multiplex PCRs, and direct sequencing is
needed in ,10% of cases. With adaptation to detect prevalent a-
globin mutations in their localities, our approach should also be
applicable in other South East Asian countries. This strategy can
be further modified by including primers for the detection of the
22MED and 2(a)20.5 double-gene deletions and becomes applic-
able in the Mediterranean area.7 However, this strategy may be
less applicable in places like Cambodia or Papua New Guinea
where access to fluorescent dye chemistry sequencing is much
more limited.
Prenatal diagnosis for Hb H disease is not routinely performed
as it is not generally regarded as a severe condition. Whether
genetic risk prediction is indicated for a non-fatal disorder that is
associated with significant morbidity, such as Hb H disease, will
have to be considered in light of recent evidence of more severe
forms of the disease, such as Hb H hydrops.16 However, current
antenatal thalassaemia screening does not usually identify
couples at risk of Hb H disease because 2a4.2 or 2a3.7 hetero-
zygous carrier state cannot be reliably detected by phenotypic
tests. Hence genetic counselling will not be offered even if Hb H
disease is included as a target for screening.
The availability of a simple and effective a-thalassaemia
genotyping strategy as proposed in the present study will
greatly facilitate carrier detection and its potential use in
antenatal screening, molecular characterisation of Hb H dis-
ease, genotype–phenotype correlation as well as longitudinal
studies on the natural history of clearly defined deletional and
non-deletional Hb H disease.
Figure 1 Strategy for genotypic diagnosis of Hb H disease by multiplex gap-PCR, multiplex ARMS-PCR and automated direct nucleotide sequencing of the
amplified a2- and a1-globin genes.
Figure 2 Electrophoretic results of multiplex
gap PCR products on 1% agarose gel in
deletional Hb H disease.
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Figure 3 Electrophoretic results of multiplex
amplification refractory mutation system
products on aqueous 8% polyacrylamide gel
in non-deletional Hb H disease. Lane M is
the 100 bp DNA size marker. The 930 bp
internal control fragment migrates at
,1200 bp on non-denaturing
polyacrylamide gel. Lanes 1, 2 and 6 are
positive for Hb CS. Lane 3 is positive for
codon 30 (DGAG). Lane 5 is positive for
Hb QS. Lane 4 is negative for all of the three
mutations. Only bands with greater intensity
than the internal control fragment after
ethidium bromide staining are regarded as
positive.
Codon 31
Figure 4 Result of direct automated sequencing of the a2-globin gene,
showing AGGRAAG mutation at codon 31. The normal allele is absent
since the patient harbours SEA deletion on the other chromosome 16.
Take-home messages
N A total of 100 haemoglobin H (Hb H) disease patients in
Hong Kong have been characterised at the DNA level.
N Single-tube multiplex gap-PCR was used to detect
22SEA,2a3.7 and 2a4.2, while Hb CS, Hb QS and
codon 30 (DGAG) were identified by single-tube multi-
plex amplification refractory mutation system (ARMS).
N Automated direct nucleotide sequencing of the amplified
a2- and a1-globin genes was performed to characterise
other non-deletional a-thalassaemia determinants.
N Based on two rapid diagnostic tests, namely multiplex
gap-PCR and multiplex ARMS, .90% of the cases were
genetically characterised.
N This laboratory strategy should be widely applicable for
genetic diagnosis of a-thalassaemia.
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